Free Trial

BioStem Technologies (OTCMKTS:BSEM) Shares Up 10% - What's Next?

BioStem Technologies logo with Medical background

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was up 10% during mid-day trading on Thursday . The stock traded as high as $11.50 and last traded at $11.50. Approximately 41,418 shares were traded during mid-day trading, a decline of 14% from the average daily volume of 48,415 shares. The stock had previously closed at $10.45.

BioStem Technologies Stock Performance

The company has a market cap of $179.96 million, a price-to-earnings ratio of 7.31 and a beta of -0.27. The firm's 50 day simple moving average is $12.56 and its 200-day simple moving average is $12.83.

BioStem Technologies (OTCMKTS:BSEM - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($1.08). The company had revenue of $72.53 million for the quarter, compared to analysts' expectations of $101.20 million. As a group, sell-side analysts expect that BioStem Technologies, Inc. will post 1.41 EPS for the current fiscal year.

BioStem Technologies Company Profile

(Get Free Report)

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

Recommended Stories

Should You Invest $1,000 in BioStem Technologies Right Now?

Before you consider BioStem Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.

While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines